Max Healthcare Institute LtdQ2 FY25
Max Healthcare Institute Ltd Q2 FY25 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Price: ₹1,081P/E: 70.0Market Cap: ₹1.0L CrSector: Healthcare Services
Management growth scorecard
Revenue
Category 2
Margin
Category 3
Fundraise
Yes
Order
N/A
Capex
Yes
2 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 2- →Max Healthcare reported a strong 27% year-on-year revenue growth in Q1 FY '26, driven by successful hospital acquisitions and integrations.
- →Existing units showed a 16% revenue growth, with like-for-like ARPOB growth of 5% year-on-year.
- →Occupancy in base hospitals is around 80%, indicating capacity constraints; growth is expected from new bed additions.
- →Approximately 1,000 brownfield and 500 greenfield beds are expected to be commissioned in FY '26, driving volume growth.
- →New hospitals like Lucknow and Nagpur are contributing significantly, with Lucknow showing 97% revenue growth year-on-year.
- →Noida and Dwarka facilities are expected to see acceleration in performance post-integration.
- →International patient revenue grew by 32% year-on-year, bolstered by expanded marketing and new geographies.
- →Net debt poised to increase by Rs. 400-500 crores to support ongoing expansion, with manageable leverage (Net debt-to-EBITDA <1.0x).
- →Oncology segment expected to grow further, increasing its share in overall hospital revenue.
Margin guidance
Category 3- →Max Healthcare reported 27% YoY growth in revenue and 23% growth in operating EBITDA in Q1 FY26, marking 19 consecutive quarters of YoY growth, indicating strong ongoing momentum.
- →Management expects continued EBITDA margin improvement in FY26, driven by better occupancy and utilization across hospitals, despite some margin pressures from superior clinical and payor mix.
- →EBITDA per bed and Return on Capital Employed (ROCE) are highlighted as more relevant metrics, expected to improve with new expansions and acquisitions.
- →New brownfield and greenfield bed capacities (~1,000 brownfield and 500 greenfield beds) are expected to start commissioning, further driving revenue and earnings growth.
- →Net debt is expected to increase modestly by Rs. 400-500 crores by FY26-end due to project funding, with Net Debt-to-EBITDA remaining under 1.0x, supporting financial stability for growth.
- →Acquisitions of lower ARPOB hospitals are targeted for strong ROCE (20-25%), contributing to overall profitable growth.
3 more insights locked — sign up free to unlock
Fundraise plans
Yes- →No specific future fundraising through equity is mentioned in the transcript.
- →Regarding debt, the company expects net debt to increase by around Rs. 400-500 crores by the end of FY '26 to fund ongoing projects.
- →This anticipated increase in net debt is related to tied-up funds for expansion projects already underway.
- →Even with this increase, the net debt-to-EBITDA ratio is expected to remain below 1.0x, indicating a manageable leverage level.
- →There is no mention of any new fundraising plans via debt or equity beyond the above increase linked to project financing.
Order book
- →Max Healthcare has several ongoing expansion projects contributing to its order book:
- → - 400 beds at Zirakpur, Mohali: Approvals received; site work progressing; expected completion within 24 months.
- → - 140 beds at Max Vaishali: Demolition underway; building plans being filed; expected completion within 30 months.
- → - 500 beds at Thane: Master plan finalizing; detailed drawings being prepared; submissions starting by end of the quarter.
- → - 250 beds at Pitampura, Delhi: Drawings submitted; site cleanup completed; construction to start upon approvals.
- → - 268 beds at Nanavati Phase 1: Advanced commissioning stages.
- → - 400 beds at Max Smart, Saket: Progressing; phased commissioning expected by end of Q2 FY '26.
- → - Max Lucknow expansion: Increasing capacity from 413 to 520 beds by FY end.
- → - 500 beds at Sector 56 Gurgaon: Structural work in progress; commissioning expected by FY end.
- → - 100 beds at Max Nagpur: Environmental clearance awaited; project expected completion in 24 months.
- → - 397 beds at Patparganj: Environmental clearance received; work in progress.
- → - 550 beds at Max Vikrant, Saket: Awaiting Forest Dept clearance; project to start after Max Smart commissioning.
- →Net debt expected to increase by Rs. 400-500 crores by FY '26 related to these projects.
Capex plans
Yes- →Max Healthcare is actively expanding with ongoing and planned projects including:
- → - 268 beds at Nanavati Phase 1, commissioning basements to third floors, starting soon.
- → - 400 beds at Max Smart, Saket Complex, with phased commissioning expected by end Q2 FY '26.
- → - Expansion at Max Lucknow to increase capacity from 413 to 520 beds by FY end.
- → - 500 beds under construction at Sector 56 Gurgaon, expected commissioning by FY end.
- → - 100 beds at Max Nagpur, awaiting environmental clearance; project to complete within 24 months.
- → - 397 beds at Patparganj, environmental clearance received, construction underway.
- → - 550 beds at Max Vikrant, Saket Complex, pending Forest Department clearance.
- → - 400 beds at Zirakpur, Mohali under fast construction, expected completion in 24 months.
- → - 140 beds expansion at Max Vaishali, demolition underway, completion in 30 months.
- → - New 130-bed built-to-suit hospital in Dehradun, Board-approved lease agreement.
- →Rs. 435 crores deployed towards capacity expansions and upgrades in Q1 FY '26.
- →Rs. 131 crores spent on land purchase for brownfield expansion at Max Vaishali.
- →Net debt expected to rise by Rs. 400-500 crores by FY '26-end to fund projects, with Net debt-to-EBITDA <1.0x.
How does Max Healthcare Institute Ltd rank vs peers in Healthcare Services?
Pro feature1Max Healthcare Institute Ltd
Rev 2Mar 3
See full Healthcare Services sector rankings
Want more stocks like Max Healthcare Institute Ltd?
Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.
Build my portfolio